SOVN

An in-ear wearable that acts on your sleep, not just records it

AmsterdamHealthBuilding

PITCHED AT THE AMSTERDAM NIGHT ON 18 AUGUST 2026

One in three adults in the developed world sleeps badly, and most wearables respond by tracking the problem in detail. SOVN pairs clinical-grade in-ear biosensing with targeted sensory stimulation so the device intervenes during the night rather than reporting on it in the morning.

The wearables market has become very good at telling people they slept badly. SOVN's bet is that measurement without intervention has reached its useful limit, and that the ear is the right place to do something about it.

In-ear sensing gets clinical-grade signal from a location people will actually tolerate overnight, and the same device delivers targeted sensory stimulation to shift sleep while it is happening. The consumer product is the wedge; licensing the sensing to healthtech developers is the second act.

⟶ Others in the room

If SOVN is your kind of company.

These founders pitched at the same startup events. The room is usually the reason people find each other.

Quail Systems

Batch release in days instead of weeks

San Francisco · Health

Brainalyze

Reading disease out of a drop of blood

San Francisco · Health

MediBridge

A health record the patient owns and can carry

London · Health

⟶ Two ways in

Companies like this one are in the room every fortnight.

FOR FOUNDERSTake the stage yourself.Five minutes, real questions from the investors in the room, and a listing here afterwards if you want one. Amsterdam runs on a steady rhythm.

Apply to pitch →Nights in Amsterdam

FOR INVESTORSGet the next ones first.The Biweekly Drop sends the companies that stood out on stage, with what they are building and where they got to. Same format as this page.

Join the drop →Browse the directory